About InnoSyn
InnoSyn is a company based in Geleen (Netherlands) founded in 2017 was acquired by Merieux Equity Partners in February 2024. InnoSyn operates in a competitive market with competitors including Ammonia, Chematur Engineering, Fidelity Oligos and EUPHOReach, among others.
- Headquarter Geleen, Netherlands
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$353.65 K (USD), Grant
Jan 01, 2024
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Acquired by
Merieux Equity Partners
(Feb 08, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of InnoSyn
Unlock access to complete
Funding Insights of InnoSyn
Investors in InnoSyn
InnoSyn has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Merieux Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pivate equity firm that focuses on investing in healthcare and nutrition companies
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for InnoSyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InnoSyn
Investment portfolio details for InnoSyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InnoSyn
Detailed financials for InnoSyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innosyn Comparisons
Peer comparison for InnoSyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InnoSyn
InnoSyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ammonia, Chematur Engineering, Fidelity Oligos and EUPHOReach, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Environmental engineering solutions for waste treatment, ammonia recovery, and biogas production.
|
|
| Locked | Locked | Locked |
Engineering firm specializing in chemical technologies, licensing, and plant delivery services.
|
|
| Locked | Locked | Locked |
Provides custom oligonucleotide synthesis and biotechnology services for scientific applications.
|
|
| Locked | Locked | Locked |
Offers software for managing chemical registrations.
|
Detailed competitors of InnoSyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innosyn
Complete news archive for InnoSyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InnoSyn
InnoSyn was founded in 2017 and raised its 1st funding round 7 years after it was founded.
InnoSyn is headquartered in Geleen, Netherlands. It is registered at Geleen, Limburg, Netherlands.
Daniel Mink is the current CEO of InnoSyn.
InnoSyn was founded in 2017 and is based in Geleen, Netherlands. Operations focus on the chemical and biotechnology sectors, where research and development of processes in biocatalysis, chemocatalysis, and flow chemistry are carried out. Services include the provision of innovative technologies and products such as recombinant pig liver esterases, hydroxy nitrile, and glucose dehydrogenase for industrial applications.
InnoSyn's top competitors include Ammonia, Chematur Engineering and Fidelity Oligos.
InnoSyn has 2 investors. Key investors include European Union, and Merieux Equity Partners.